US Stock MarketDetailed Quotes

PBM Psyence Biomedical

Watchlist
  • 0.537
  • +0.008+1.53%
Close Aug 16 16:00 ET
8.87MMarket Cap-140P/E (TTM)

Psyence Biomedical Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Mar 31, 2024
(Q2)Sep 30, 2023
(FY)Mar 31, 2023
(FY)Mar 31, 2022
(FY)Mar 31, 2021
Assets
Current assets
Cash, cash equivalents and short term investments
-45.05%733.19K
--598.38K
-23.79%1.33M
-63.17%1.75M
--4.75M
-Cash and cash equivalents
-45.05%733.19K
--598.38K
-23.79%1.33M
-63.17%1.75M
--4.75M
Receivables
-72.05%41.75K
--18.69K
277.71%149.37K
-71.36%39.55K
--138.07K
-Other receivables
-72.05%41.75K
--18.69K
277.71%149.37K
-71.36%39.55K
--138.07K
Prepaid assets
318.07%322.13K
--15.44K
1,329.54%77.05K
-1.24%5.39K
--5.46K
Restricted cash
0.19%29.61K
--33.27K
-18.41%29.56K
814.56%36.23K
--3.96K
Total current assets
-29.15%1.13M
--665.78K
-13.20%1.59M
-62.63%1.83M
--4.9M
Non current assets
Net PPE
--5.49K
----
--0
----
----
-Gross PPE
--5.73K
----
--0
----
----
-Accumulated depreciation
---240
----
--0
----
----
Total non current assets
--5.49K
--0
--0
--0
--0
Total assets
-28.81%1.13M
--665.78K
-13.20%1.59M
-62.63%1.83M
--4.9M
Liabilities
Current liabilities
Payables
-65.46%562.35K
--910.08K
4,313.67%1.63M
174.29%36.89K
--13.45K
-accounts payable
-65.46%562.35K
--910.08K
4,313.67%1.63M
174.29%36.89K
--13.45K
Current accrued expenses
-22.52%125.95K
----
71.34%162.56K
8.27%94.87K
--87.63K
Current provisions
--66.9K
----
----
----
----
Current debt and capital lease obligation
--10.45M
--733.09K
----
----
----
-Current debt
--10.45M
--733.09K
----
----
----
Other current liabilities
--901.61K
----
----
----
----
Current liabilities
575.98%12.1M
--1.64M
1,259.04%1.79M
30.36%131.76K
--101.08K
Non current liabilities
Total non current liabilities
--0
--0
--0
--0
--0
Total liabilities
575.98%12.1M
--1.64M
1,259.04%1.79M
30.36%131.76K
--101.08K
Shareholders'equity
Share capital
677.29%46.13M
----
--5.93M
----
----
-common stock
677.29%46.13M
----
--5.93M
----
----
Retained earnings
-812.06%-57.46M
----
---6.3M
----
----
Gains losses not affecting retained earnings
118.35%361.06K
----
--165.36K
----
----
Other equity interest
----
----
----
-64.58%1.7M
--4.8M
Total stockholders'equity
-5,374.09%-10.97M
---977.39K
-111.79%-200.45K
-64.58%1.7M
--4.8M
Total equity
-5,374.09%-10.97M
---977.39K
-111.79%-200.45K
-64.58%1.7M
--4.8M
Currency Unit
USD
USD
USD
USD
USD
Audit Opinions
Unqualified Opinion with Explanatory Notes
--
--
--
--
(FY)Mar 31, 2024(Q2)Sep 30, 2023(FY)Mar 31, 2023(FY)Mar 31, 2022(FY)Mar 31, 2021
Assets
Current assets
Cash, cash equivalents and short term investments -45.05%733.19K--598.38K-23.79%1.33M-63.17%1.75M--4.75M
-Cash and cash equivalents -45.05%733.19K--598.38K-23.79%1.33M-63.17%1.75M--4.75M
Receivables -72.05%41.75K--18.69K277.71%149.37K-71.36%39.55K--138.07K
-Other receivables -72.05%41.75K--18.69K277.71%149.37K-71.36%39.55K--138.07K
Prepaid assets 318.07%322.13K--15.44K1,329.54%77.05K-1.24%5.39K--5.46K
Restricted cash 0.19%29.61K--33.27K-18.41%29.56K814.56%36.23K--3.96K
Total current assets -29.15%1.13M--665.78K-13.20%1.59M-62.63%1.83M--4.9M
Non current assets
Net PPE --5.49K------0--------
-Gross PPE --5.73K------0--------
-Accumulated depreciation ---240------0--------
Total non current assets --5.49K--0--0--0--0
Total assets -28.81%1.13M--665.78K-13.20%1.59M-62.63%1.83M--4.9M
Liabilities
Current liabilities
Payables -65.46%562.35K--910.08K4,313.67%1.63M174.29%36.89K--13.45K
-accounts payable -65.46%562.35K--910.08K4,313.67%1.63M174.29%36.89K--13.45K
Current accrued expenses -22.52%125.95K----71.34%162.56K8.27%94.87K--87.63K
Current provisions --66.9K----------------
Current debt and capital lease obligation --10.45M--733.09K------------
-Current debt --10.45M--733.09K------------
Other current liabilities --901.61K----------------
Current liabilities 575.98%12.1M--1.64M1,259.04%1.79M30.36%131.76K--101.08K
Non current liabilities
Total non current liabilities --0--0--0--0--0
Total liabilities 575.98%12.1M--1.64M1,259.04%1.79M30.36%131.76K--101.08K
Shareholders'equity
Share capital 677.29%46.13M------5.93M--------
-common stock 677.29%46.13M------5.93M--------
Retained earnings -812.06%-57.46M-------6.3M--------
Gains losses not affecting retained earnings 118.35%361.06K------165.36K--------
Other equity interest -------------64.58%1.7M--4.8M
Total stockholders'equity -5,374.09%-10.97M---977.39K-111.79%-200.45K-64.58%1.7M--4.8M
Total equity -5,374.09%-10.97M---977.39K-111.79%-200.45K-64.58%1.7M--4.8M
Currency Unit USDUSDUSDUSDUSD
Audit Opinions Unqualified Opinion with Explanatory Notes--------

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg